Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-09

Clinical Trial Update: Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis. [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting on the use of Pimecrolimus Cream 1% (Elidel) and a Medicated Device Cream (Eletone) for treatment and maintenance of Atopic Derma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elidel (pimecrolimus)
  • Medicated Device Cream (Eletone)

Snippet

Sponsor: Emer, Jason, M.D. | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED